Lipid-lowering effect of tenofovir in HIV-infected patients

被引：27
|
作者：
Fabbiani, Massimiliano [1 ]
Bracciale, Laura [1 ]
Doino, Maria [1 ]
Sidella, Letizia [1 ]
Farina, Salvatore [1 ]
Di Cristo, Valentina [1 ]
Cauda, Roberto [1 ]
De Luca, Andrea [1 ,2 ]
Di Giambenedetto, Simona [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, I-00168 Rome, Italy
[2] Siena Univ Hosp, Infect Dis Unit 2, Siena, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2011年 / 66卷 / 03期
关键词：
cholesterol; simplification; antiretroviral therapy; cardiovascular risk;
D O I：
10.1093/jac/dkq464
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：682 / 683
页数：2
相关论文
共 50 条
  • [31] Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
    Walti, Laura N.
    Steinrucken, Julia
    Rauch, Andri
    Wandeler, Gilles
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (11):
  • [32] Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profiles
    Behrens, Georg
    Maserati, Renato
    Rieger, Armin
    Domingo, Pere
    Abel, Florian
    Wang, Hui
    Pearce, Gill
    ANTIVIRAL THERAPY, 2012, 17 (06) : 1011 - 1020
  • [33] The lipid-lowering effect of atorvastatin in Taiwanese diabetic patients with hyperlipidemia
    Chang, Chwen-Tzuei
    Lee, Jenn-Kuen
    Lin, Jen-Der
    Hung, Yi-Jen
    Liu, Rue-Tsuan
    Shau, Wen-Yi
    Sheu, Wayne Huey-Herng
    TZU CHI MEDICAL JOURNAL, 2013, 25 (03): : 168 - 174
  • [34] Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction
    Sabin, C. A.
    Monforte, A. d'Arminio
    Friis-Moller, N.
    Weber, R.
    El-Sadr, W. M.
    Reiss, P.
    Kirk, O.
    Mercie, P.
    Law, M. G.
    De Wit, S.
    Pradier, C.
    Phillips, A. N.
    Lundgren, J. D.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (07) : 1101 - 1110
  • [35] Lipid disorders in HIV-infected patients with myocardial infarction
    Richter, W. O.
    Schnaitmann, E.
    Issler, E.
    Trein, A.
    ANTIVIRAL THERAPY, 2010, 15 (08) : A49 - A49
  • [36] Vascular and lipid syndromes in selected HIV-infected patients
    SoRelle, R
    CIRCULATION, 1998, 98 (09) : 829 - 830
  • [37] Lipid-lowering effect of orlistat in Filipino patients: An RCT study
    Litonjua, A
    Sy, R
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S141 - S141
  • [38] THE LIPID-LOWERING EFFECT OF PANTETHINE IN HYPERLIPIDEMIC PATIENTS - A CLINICAL INVESTIGATION
    GALEONE, F
    SCALABRINO, A
    GIUNTOLI, F
    BIRINDELLI, A
    PANIGADA, G
    ROSSI, A
    SABA, P
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 34 (02): : 383 - 390
  • [39] Lipid disorders in HIV-infected patients with myocardial infarction
    Richter, W. O.
    Schnaitmann, E.
    Issler, E.
    Trein, A.
    ANTIVIRAL THERAPY, 2010, 15 : A49 - A49
  • [40] The Lipid-Lowering Effect of Atorvastatin in Acute Coronary Syndrome Patients
    Ying, Ku Ming
    Tan, S. S. N.
    Tan, C. S. Y.
    Tiong, L. L.
    Lim, A. M. W.
    Ling, D. E.
    Hii, E. H. H.
    Kiu, I. S. N.
    Wong, L. W.
    Ting, M. L. L.
    Sumbai, M. E.
    Chua, A. T. P.
    Douglas, J. S.
    Theng, M. L.
    Chew, S. W.
    Fong, A. Y. Y.
    Ong, T. K.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 7 - 8
12345